BLIS M18 is the second oral-health probiotic strain from Blis Technologies and its North American distributor Stratum Nutrition.
Photo © iStockphoto.com/Kurhan
BLIS M18, the second oral-health probiotic strain from Blis Technologies (Dunedin, NZ) and its North American distributor Stratum Nutrition (Carthage, MO), has received a “Letter of No Objection” from the U.S. FDA in responses to a filing for Generally Recognized as Safe (GRAS) status.
Blis Technologies previously received a Letter of No Objection GRAS response for its first, well-known oral-health probiotic strain BLIS K12. Said the companies in a press release: “GRAS status adds a new level of credibility for BLIS M18 and has the potential to open up opportunities with larger consumer food and beverage companies in the U.S., but also is recognized as a relevant and credible safety assessment by other countries and multinational companies.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.